Literature DB >> 15987234

The role of oxidative stress in the pathogenesis of COPD: implications for therapy.

Irfan Rahman1.   

Abstract

Chronic inflammation and oxidative stress are important features in the pathogenesis of COPD. The increased oxidative stress in patients with COPD is the result of an increased burden of inhaled oxidants, as well as increased amounts of reactive oxygen species (ROS) generated by various inflammatory, immune and epithelial cells of the airways. Oxidative stress has important implications on several events of lung physiology and for the pathogenesis of COPD. These include oxidative inactivation of antiproteases and surfactants, mucus hypersecretion, membrane lipid peroxidation, mitochondrial respiration, alveolar epithelial injury, remodeling of extracellular matrix, and apoptosis. An increased level of ROS produced in the airways is reflected by increased markers of oxidative stress in the airspaces, sputum, breath, lungs, and blood in patients with COPD. The biomarkers of oxidative stress such as H2O2, F2-isoprostanes, malondialdehyde and 4-hydroxy-2-nonenal have been successfully measured in breath condensate. ROS and aldehydes play a key role in enhancing the inflammation through the activation of mitogen-activated protein kinases and redox-sensitive transcription factors such as nuclear factor kappa B and activator protein-1. Oxidative stress also alters nuclear histone acetylation and deacetylation leading to increased gene expression of pro-inflammatory mediators in the lung. Oxidative stress may play a role in the poor clinical efficacy of corticosteroids in the treatment of COPD. Since a variety of oxidants, free radicals, and aldehydes are implicated in the pathogenesis of COPD it is likely that a combination of antioxidants may be effective in the treatment of COPD. Antioxidant compounds may also be of therapeutic value in monitoring oxidative biomarkers indicating disease progression. Various approaches to enhance the lung antioxidant screen and the clinical effectiveness of antioxidant compounds in the treatment of COPD are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987234     DOI: 10.2165/00151829-200504030-00003

Source DB:  PubMed          Journal:  Treat Respir Med        ISSN: 1176-3450


  42 in total

Review 1.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

2.  Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure.

Authors:  Alessia Garramone; Roberto Cangemi; Emanuela Bresciani; Roberto Carnevale; Simona Bartimoccia; Elisa Fante; Marco Corinti; Marco Brunori; Francesco Violi; Giuliano Bertazzoni; Pasquale Pignatelli
Journal:  Intern Emerg Med       Date:  2017-09-15       Impact factor: 3.397

3.  Oxidative stress management during non-invasive ventilation in acute respiratory failure.

Authors:  Matteo Becatti; Niccolò Taddei; Claudia Fiorillo
Journal:  Intern Emerg Med       Date:  2017-12-21       Impact factor: 3.397

4.  Oral antioxidants improve leg blood flow during exercise in patients with chronic obstructive pulmonary disease.

Authors:  Matthew J Rossman; Joel D Trinity; Ryan S Garten; Stephen J Ives; Jamie D Conklin; Zachary Barrett-O'Keefe; Melissa A H Witman; Amber D Bledsoe; David E Morgan; Sean Runnels; Van R Reese; Jia Zhao; Markus Amann; D Walter Wray; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

Review 5.  Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.

Authors:  Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2012-11-06       Impact factor: 8.401

6.  Evaluation of the antioxidant activity of root extract of pepper fruit (Dennetia tripetala), and it's potential for the inhibition of lipid peroxidation.

Authors:  Ngozi Paulinus Okolie; Abiodun Falodun; Oluseyi Davids
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

7.  Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.

Authors:  Davood Attaran; Shahrzad M Lari; Mohammad Towhidi; Hassan Ghobadi Marallu; Hossein Ayatollahi; Mohammad Khajehdaluee; Mostafa Ghanei; Reza Basiri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 8.  Environmental toxicity, redox signaling and lung inflammation: the role of glutathione.

Authors:  Saibal K Biswas; Irfan Rahman
Journal:  Mol Aspects Med       Date:  2008-08-08

9.  Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells.

Authors:  Simone Filosto; David S Baston; Samuel Chung; Cathleen R Becker; Tzipora Goldkorn
Journal:  Mol Cancer Ther       Date:  2013-05-17       Impact factor: 6.261

Review 10.  Extracellular superoxide dismutase and risk of COPD.

Authors:  Rebecca E Oberley-Deegan; Elizabeth A Regan; Vuokko L Kinnula; James D Crapo
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.